International Journal of Hematology

DOI: 10.1007/s12185-018-2456-9 Pages: 717-719

Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration

1. Wakayama Medical University, Hematology/Oncology

2. Institute of Biomedical Research and Innovation, Department of Cell Therapy

3. Institute of Research, Tokyo Medical and Dental University, Division of Advanced Biomedical Engineering Research, Center for Stem Cell and Regenerative Medicine

4. Osaka Red Cross Hospital, Department of Hematology

5. National Hospital Organization, Kumamoto Minami Hospital, Department of General Medicine

Correspondence to:
Takashi Sonoki
Tel: +81-73-441-0665
Email: sonoki@wakayama-med.ac.jp

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge